Evidence map›Paper›PMID 39877489›Full record

ArticleNigerian medical journal : journal of the Nigeria Medical Association

Factors Associated with Microalbuminuria among Children with Sickle Cell Disease in a Tertiary Centre in South-South Nigeria.

Datonye Christopher Briggs, Chioma Okechukwu, Josiah Apollus, Ijeoma Amadi, Hannah Omunakwe, Linda Anucha Dublin-Green, Dorathy Okoh

Abstract read
In one paragraph

Article in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Datonye Christopher BriggsPaediatric Nephrology division, Department of Paediatrics, Rivers State University Teaching Hospital & Faculty of Clinical Sciences, Rivers State University, Nigeria.
Chioma OkechukwuPaediatric Haemato-oncology unit, Department of Paediatrics, Rivers State University Teaching Hospital & Faculty of Clinical Sciences, Rivers State University, Nigeria.
Josiah ApollusPaediatric Haemato-oncology unit, Department of Paediatrics, Rivers State University Teaching Hospital & Faculty of Clinical Sciences, Rivers State University, Nigeria.
Ijeoma AmadiPaediatric Haemato-oncology unit, Department of Paediatrics, Rivers State University Teaching Hospital & Faculty of Clinical Sciences, Rivers State University, Nigeria.
Hannah OmunakwePaediatric Nephrology division, Department of Paediatrics, Rivers State University Teaching Hospital & Faculty of Clinical Sciences, Rivers State University, Nigeria.
Linda Anucha Dublin-GreenDepartment of Haematology and Blood Transfusion, Rivers State University Teaching Hospital & Faculty of Basic Clinical Sciences, Rivers State University, Nigeria.
Dorathy OkohDepartment of Haematology and Blood Transfusion, Rivers State University Teaching Hospital & Faculty of Basic Clinical Sciences, Rivers State University, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Microalbuminuria, an early indicator of kidney damage in Sickle Cell Disease (SCD) patients, is linked to a heightened risk of chronic kidney disease (CKD) in adulthood. This study investigates the determinants of microalbuminuria in paediatric SCD patients in South-South Nigeria. Methodology: This cross-sectional study was conducted over six months at the Rivers State University Teaching Hospital, Nigeria, involving 60 children with [HbSS genotype, SCD] in a steady state. Data collection included demographics, past medical history, clinical measurements, and laboratory assessments of urine and blood samples. 'Steady state' was defined as SCD with a known 'steady state' haemoglobin level and stable clinical state for ≥ 3 months. Microalbuminuria was defined spot urine albumin-creatinine ratio of 30mg/g to <300 mg/g. Results: Of the 60 children recruited, 31 children (51.7%) were males. The mean age was 9.6 ± 4.3 years. The prevalence of microalbuminuria was 16.7% (CI: 8.29 - 28.5%) and associated risk factors were hypertension (p = 0.017), use of Hydroxyurea (p = 0.008), and Ciklavit (p = 0.025), but not NSAIDs (p = 0.046). There was a significant negative correlation (ɼ = -0.28; p = 0.032) between haemoglobin level and microalbuminuria. Conclusion: This study provides insights into the factors associated with microalbuminuria in children with SCD in our setting and highlights the need for early screening for markers of CKD among children with SCD. Further research is needed to ascertain the potential benefits of addressing anaemia and reducing haemolysis in mitigating the occurrence of microalbuminuria among children with SCD.

Indexed as

ChildrenMicroalbuminuriaRisk FactorsSickle Cell DiseaseSickle Cell Nephropathy

Identifiers

PMID39877489
PMCPMC11770667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.